Symposia: Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Lymphoid Leukemias, ALL, Combination therapy, Adult, Translational Research, Clinical Research, Diseases, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Adverse Events, Study Population, Human, Measurable Residual Disease
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Lymphoid Leukemias, ALL, Combination therapy, Adult, Translational Research, Clinical Research, Diseases, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Adverse Events, Study Population, Human, Measurable Residual Disease
Monday, December 9, 2024: 2:45 PM-4:15 PM
Marriott Grand Ballroom 2-4
(Marriott Marquis San Diego Marina)
Moderators:
Guru Subramanian Guru Murthy, MBBS, Medical College of Wisconsin
and
Anjali S. Advani, MD, Cleveland Clinic Taussig Cancer Institute
Disclosures:
Advani: MJH Life: Honoraria; Kite: Consultancy, Research Funding; Wolters Kluwer: Honoraria; Web MD: Honoraria; Emmes: Honoraria; PER: Honoraria; American Society of Hematology: Honoraria; Wiley: Honoraria; Pfizer: Other: Manuscript help, Research Funding; Glycomimetics: Research Funding; Springer: Honoraria; MD Education: Honoraria; Amgen: Research Funding; BEAM: Other: Research support, Research Funding; OBI: Research Funding; Incyte: Research Funding; Immunogen: Research Funding; Seattle Genetics: Research Funding; Macrogenics: Research Funding; Servier: Research Funding; Kura: Research Funding; Novartis: Consultancy.
2:45 PM
3:00 PM
3:15 PM
3:30 PM
3:45 PM
4:00 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH